Yankees Score with ...
Health Care: Drugs
Omeros Corporation (OMER: NASDAQ)
$5.30 0.22 | 4.33%
05/24/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 6.02M | 4.52M | 2.10M | 1.44M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 6.02M | 4.52M | 2.10M | 1.44M |
| Selling, General, and Administrative Expenses | 10.98M | 8.22M | 8.75M | 5.27M |
| Research & Development | 31.92M | 23.72M | 23.46M | 16.93M |
| Operating Income before D & A (EBITDA) | -36.88M | -27.41M | -30.11M | -20.76M |
| Depreciation & Amortization | 320.00K | 435.00K | 472.00K | 451.00K |
| Interest Income | 40.00K | 0.00 | 0.00 | 0.00 |
| Other Income - Net | 130.00K | 748.00K | 2.39M | 1.87M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -37.04M | -27.10M | -28.19M | -19.34M |
| Interest Expense | 1.73M | 1.88M | 1.54M | 2.20M |
| Pre-Tax Income | -38.76M | -28.98M | -29.72M | -21.54M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -38.44M | 0.00 | -29.25M | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -38.44M | 0.00 | -29.25M | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -38.44M | -28.55M | -29.25M | -21.09M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-38.44M | 0.00 | -29.25M | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -38.44M | 0.00 | -29.25M | 0.00 |
| Basic EPS from Continuing Ops. | -1.59 | -1.29 | -1.37 | -2.92 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.59 | -1.29 | -1.37 | -2.92 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.59 | -1.29 | -1.37 | -2.92 |
| Basic Normalized Net Income/Share | -1.59 | n.a. | -1.37 | n.a. |
| EPS fr Continuing Ops. | -1.59 | -1.29 | -1.37 | -2.92 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.59 | -1.29 | -1.37 | -2.92 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.59 | -1.29 | -1.37 | -2.92 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.59 | n.a. | -1.37 | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with OMER
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
Latest OMER Headlines from TheStreet
- Short Interest Jumps 41.2% For OMER 05.10.13 | 03:05 pm
- 5 Stocks Insiders are Scooping Up 01.09.13 | 12:01 pm
- Top Insider Trades: FB LNKD SMM OMER 01.07.13 | 08:01 am
- Omeros Stock Gaps Down On Today's Open (OMER) 06.27.12 | 09:06 am
- 7 Stocks Soaring on Unusual Volume 06.08.12 | 04:06 pm
- 10 Stocks to Watch: Krispy Kreme, Omeros 04.01.11 | 01:04 pm
- Omeros Stock Gaps Down On Today's Open (OMER) 04.01.11 | 09:04 am
- Omeros, EXFO: After-Hours Trading 03.31.11 | 05:03 pm
- IPO Comeback In 2009 Sets Stage For Busy 2010 12.31.09 | 10:12 am
- Worst IPOs of 2009: Biggest Stock Flops 12.15.09 | 10:12 am
Press Releases for OMER
- Investigational New Drug Application Cleared By FDA For OMS824 In Huntington's Disease - PR Newswire 05.23.13 | 07:05 am
- Omeros To Present At Two Upcoming Conferences - PR Newswire 05.22.13 | 07:05 am
- Omeros Announces Closing Of $16.2 Million Registered Direct Offering Of Common Stock - PR Newswire 05.14.13 | 12:05 pm
- Omeros Announces $16.2 Million Registered Direct Offering Of Common Stock - PR Newswire 05.09.13 | 06:05 pm
- Omeros Requests Fast Track Designation For OMS824 For The Treatment Of Huntington's Disease - PR Newswire 05.01.13 | 07:05 am
- Omeros Ophthalmology Product OMS302 Granted Eligibility For European Centralized Review - PR Newswire 04.30.13 | 07:04 am
- Omeros Reports OMS302 Clinical Data Presented At The Annual ASCRS And ASOA Symposium And Congress - PR Newswire 04.25.13 | 07:04 am
- Omeros To Present At The 12th Annual Needham Healthcare Conference - PR Newswire 04.24.13 | 07:04 am
- Omeros To Present Additional OMS302 Clinical Data At The Annual ASCRS And ASOA Symposium And Congress - PR Newswire 04.19.13 | 07:04 am
- Omeros Files Orphan Drug Application For Treatment Of Atypical Hemolytic Uremic Syndrome With OMS721 - PR Newswire 04.17.13 | 07:04 am
Partner Headlines for OMER
- Is This Biotech A Value Stock Or Value Trap? - Seeking Alpha 03.30.13 | 06:03 am
- Do You Have The Guts To Take On Cutting-Edge Biotech Like This VC? - Seeking Alpha 12.14.12 | 09:12 am
- From Earlier: Investigational New Drug Application Cleared for Omeros' Lead Compound in PDE10 Program - Benzinga 10.02.12 | 09:10 am
- Netflix REITERATED Below Average and 3 Analyst-Reiterated Ratings Starting the Week - Wall St. Cheat Sheet 07.23.12 | 04:07 am
- Market Wrap: Markets RALLY, Arena Makes HISTORY, Apple BEATS Samsung - Wall St. Cheat Sheet 06.28.12 | 09:06 am
- Ultimate Market Recap: News Corp. Makes Split Decision, RIM Looking Rough - Wall St. Cheat Sheet 06.28.12 | 08:06 am
- Omeros Eyeing Deals As Ophthalmology Drug Succeeds - Seeking Alpha 03.15.12 | 09:03 am
- UPDATE: Canaccord Upgrades Omeros; Raises PT - Benzinga 03.14.12 | 09:03 am
- UPDATE: Rodman & Renshaw Upgrades Omeros to Outperform - Benzinga 12.05.11 | 09:12 am
- A Bullish Speculative Options Bet and a Bearish One - Seeking Alpha 06.30.11 | 09:06 am
